Skip to main content
. 2024 May 6;69(9):641–687. doi: 10.1177/07067437241245384

Table 3.5.

Summary of Comparative Favourability Ratings for First-Line Antidepressants: Efficacy, Acceptability, Drug Interactions, Discontinuation Effects, and Tolerability Issues.

Q.3.e.